SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-000041
Filing Date
2023-01-03
Accepted
2023-01-03 16:10:52
Documents
1
Period of Report
2022-12-30

Document Format Files

Seq Description Document Type Size
1 form4-01032023_090116.html 4  
1 form4-01032023_090116.xml 4 4049
  Complete submission text file 0001415889-23-000041.txt   5517
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Singh Shawn (Reporting) CIK: 0001412071 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 23502182